IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MWG Management Ltd.

Q1 2022 Holdings

Filed 2022-05-16 | 2 holdings | $134.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beam Therapeutics Inc(BEAM)COM07373V105$134.5M2,346,93499.9%
Lyell Immunopharma IncCOM55083R104$101.8K20,162,3320.1%